Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention.
CONCLUSION: Newly diagnosed DM based on peri-procedural HbA1c is common and associated with increased short and long term risk for adverse outcomes. Ours may warrant routine screening for DM in all patients undergoing PCI.
PMID: 27665509 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - Category: Internal Medicine Authors: Tailakh MA, Friger M, Zahger D, Sidi A, Mazor-Dray E, Novack V Tags: Eur J Intern Med Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Attack | Internal Medicine | Percutaneous Coronary Intervention | Stroke | Study